Tag: acute respiratory distress syndrome
January 23, 2019
Athersys Announces Positive Results From Its Exploratory Clinical Study of MultiStem Cell Therapy
Athersys (NASDAQ:ATHX) announced summary results from its exploratory clinical study of the intravenous administration of MultiStem® cell therapy to treat... June 7, 2018
Athersys Announces Expansion of Collaboration With Healios
Athersys (NASDAQ:ATHX) announced today that it has entered into an agreement with HEALIOS K.K. to expand their collaboration into additional... January 29, 2018
Faron Pharmaceuticals: FDA grants Fast Track Designation to Faron for Traumakine®
Faron Pharmaceuticals (AIM: FARN), the clinical stage biopharmaceutical company, announces it has received Fast Track designation from the US Food... January 24, 2018
FDA has approved Faron's Traumakine® IND
Faron Pharmaceuticals (AIM: FARN) a clinical stage biopharmaceutical company, announced the US Food and Drug Administration has approved the Investigational... May 8, 2017